European equities traded in the US as American depositary receipts were dropping sharply late Friday morning, falling 1.89% to 1,275.63 on the S&P Europe Select ADR Index, which is down 4.6% for the week.
From continental Europe, the gainers were led by furniture maker Natuzzi (NTZ) and telecommunications company VEON (VEON), which advanced 8.4% and 3.4%, respectively. They were followed by medical device maker EDAP TMS (EDAP) and biotech firm BioNTech (BNTX), which increased 1.9% and 1.3%, respectively.
The decliners from continental Europe were led by pharmaceutical company Novo Nordisk (NVO) and accommodations booking company trivago (TRVG), which fell 20% and 5.3%, respectively. They were followed by biopharmaceutical company Cellectis (CLLS) and 3D printer company Materialise (MTLS), which were down 2.1% and 1.7%, respectively.
From the UK and Ireland, the gainers were led by biotech firm Autolus Therapeutics (AUTL) and cruise line operator Carnival (CUK), which rose 3.8% and 3.3%, respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and pharmaceutical company Silence Therapeutics (SLN), which were up 2.7% and 2.6%, respectively.
The decliners from the UK and Ireland were led by biopharmaceutical company Mereo BioPharma Group (MREO) and software firm Endava (DAVA), which were down 2.4% and 1.6%, respectively. They were followed by biotech firm Trinity Biotech (TRIB) and alcoholic beverage company Diageo (DEO), down 1.2% and 1%, respectively.
Comments